Fisher Asset Management
TNGX icon

Fisher Asset Management’s Tango Therapeutics TNGX Stock Holding History

Fisher Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Buy
578,158
+415,759
+256% +$10.3M 0.01% 349
2026
Q1 		$3.4M Sell
162,399
-25,294
-13% -$352K ﹤0.01% 504
2025
Q4 		$1.66M Sell
187,693
-22,659
-11% -$195K ﹤0.01% 588
2025
Q3 		$1.77M Sell
210,352
-13,725
-6% -$92.9K ﹤0.01% 596
2025
Q2 		$1.15M Hold
224,077
– – ﹤0.01% 679
2025
Q1 		$307K Buy
224,077
+69,130
+45% +$170K ﹤0.01% 890
2024
Q4 		$479K Hold
154,947
– – ﹤0.01% 779
2024
Q3 		$1.19M Hold
154,947
– – ﹤0.01% 642
2024
Q2 		$1.33M Buy
154,947
+54,256
+54% +$419K ﹤0.01% 639
2024
Q1 		$799K Hold
100,691
– – ﹤0.01% 706
2023
Q4 		$997K Buy
+100,691
New +$874K ﹤0.01% 692

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fisher Asset Management's TNGX Position: Q2 2026 in Review

Fisher Asset Management increased its Tango Therapeutics (TNGX) stake by 256% in Q2 2026, buying an estimated $10.3M and bringing the position to 578,158 shares worth $18.1M. The position accounts for 0.01% of the portfolio, ranked #349.

Fisher Asset Management first reported a position in TNGX in Q4 2023 and has held it in 11 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Fisher Asset Management held 578,158 shares of Tango Therapeutics worth $18.1M as of Q2 2026.
  • Fisher Asset Management bought 415,759 Tango Therapeutics shares in Q2 2026, an estimated $10.3M.
  • Tango Therapeutics made up 0.01% of Fisher Asset Management's portfolio in Q2 2026, its #349 holding.
  • Fisher Asset Management first reported a position in Tango Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.